Sunday, June 14, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 972 of 1,261

  1. US 7893256

    Azabicycloalkane compounds

    Theravance, Inc. · Granted Feb 22, 2011 · Expires Feb 17, 2031

    granted

  2. US 7893206

    Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof

    Xenon Pharmaceuticals Inc. · Granted Feb 22, 2011 · Expires Feb 17, 2031

    granted

  3. US 7893033

    Targeting proteins to deliver therapeutic or diagnostic reagents

    The Board of Regents of the University of Texas System · Granted Feb 22, 2011 · Expires Feb 17, 2031

    granted

  4. US 7892786

    Methods for expression and purification of immunotoxins

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 22, 2011 · Expires Feb 17, 2031

    granted

  5. US 7892730

    Compositions and methods for cancer

    Sagres Discovery, Inc. · Granted Feb 22, 2011 · Expires Feb 17, 2031

    granted

  6. US 7893022

    Anti-angiogenic methods and compositions

    Sangamo Biosciences, Inc. · Granted Feb 22, 2011 · Expires Feb 17, 2031

    granted

  7. US 7887818

    Neospora caninum vaccine

    The United States of America, as represented by the Secretary of Agriculture · Granted Feb 15, 2011 · Expires Feb 10, 2031

    granted

  8. US 7888121

    Methods and compositions for targeted cleavage and recombination

    Sangamo Biosciences, Inc. · Granted Feb 15, 2011 · Expires Feb 10, 2031

    granted

  9. US 7888116

    Uses of notch receptors, notch ligands, and notch modulators in methods related to metabolic diseases

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 15, 2011 · Expires Feb 10, 2031

    granted

  10. US 7888070

    Nucleic acids encoding growth hormone with a modified RSP sorting signal

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Feb 15, 2011 · Expires Feb 10, 2031

    granted

  11. US 7888069

    Plant-made west nile virus (WNV) vaccines, vectors and plant codon optimized sequences

    The United States of America as represented by the Secretary of Argriculture · Granted Feb 15, 2011 · Expires Feb 10, 2031

    granted

  12. US 7888068

    Cloning of honey bee allergen C

    PLS-Design GmbH · Granted Feb 15, 2011 · Expires Feb 10, 2031

    granted

  13. US 7887836

    Compositions and methods for treating lymphoma

    The Board of Regents of the University of Texas System · Granted Feb 15, 2011 · Expires Feb 10, 2031

    granted

  14. US 7887829

    Mucosal cell composites and methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 15, 2011 · Expires Feb 10, 2031

    granted

  15. US 7887812

    Live attenuated Leishmania vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 15, 2011 · Expires Feb 10, 2031

    granted

  16. US 7887789

    Polymer derivatives having particular atom arrangements

    Nektar Therapeutics · Granted Feb 15, 2011 · Expires Feb 10, 2031

    granted

  17. US 7888498

    Compositions and methods for inhibiting expression of IKK-B gene

    Alnylam Pharmaceuticals, Inc. · Granted Feb 15, 2011 · Expires Feb 10, 2031

    granted

  18. US 7888386

    3-(phenoxyphenylmethyl)pyrrolidine compounds

    Theravance, Inc. · Granted Feb 15, 2011 · Expires Feb 10, 2031

    granted

  19. US 7888389

    Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 15, 2011 · Expires Feb 10, 2031

    granted

  20. US 7888372

    Compositions and methods for modulating bone mineral deposition

    The Regents of the University of California · Granted Feb 15, 2011 · Expires Feb 10, 2031

    granted

  21. US 7888384

    Heterocyclic derivatives for modulation of calcium channels

    Vertex Pharmaceuticals Incorporated · Granted Feb 15, 2011 · Expires Feb 10, 2031

    granted

  22. US 7888357

    Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death

    Northwestern University · Granted Feb 15, 2011 · Expires Feb 10, 2031

    granted

  23. US 7888332

    Hydrazide-containing CFTR inhibitor compounds and uses thereof

    The Regents of the University of California · Granted Feb 15, 2011 · Expires Feb 10, 2031

    granted

  24. CA 2760177

    FORMULATION ALIMENTAIRE COMPRENANT DU GLYCOGENE

    ACRAF [IT] · Granted Feb 10, 2011 · Expires Feb 5, 2031

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.